A Phase 1, First-in-Human, Open-Label, Dose-Escalation Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of LM-061 Tablet in Subjects with Advanaced Tumours

  • Richardson, Gary (Primary Chief Investigator (PCI))
  • Lai, Li Hoon (Project Manager)

Project: Research

Project Details

StatusActive
Effective start/end date14/07/2131/12/24

Keywords

  • Pharmacokinetics
  • Oncology
  • Tumours
  • Clinical trial